Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation
- 14 August 2014
- journal article
- Published by American Society of Hematology in Blood
- Vol. 124 (7), 1119-1126
- https://doi.org/10.1182/blood-2013-12-543793
Abstract
Histiocytoses are a group of heterogeneous diseases that mostly comprise Langerhans cell histiocytosis (LCH) and non-LCH. The association of LCH with non-LCH is exceptional. We report 23 patients with biopsy-proven LCH associated with Erdheim-Chester disease (ECD) (mixed histiocytosis) and discuss the significance of this association. We compare the clinical phenotypes of these patients with those of 56 patients with isolated LCH and 53 patients with isolated ECD. The average age at diagnosis was 43 years. ECD followed (n = 12) or was diagnosed simultaneously with (n = 11) but never preceded LCH. Although heterogeneous, the phenotype of patients with mixed histiocytosis was closer to that of isolated ECD than to that of isolated LCH (principal component analysis). LCH and ECD improved in response to interferon alpha-2a treatment in only 50% of patients (8 of 16). We found the BRAFV600E mutation in 11 (69%) of 16 LCH lesions and in 9 (82%) of 11 ECD lesions. Eight patients had mutations in both ECD and LCH biopsies. Our findings indicate that the association of LCH and ECD is not fortuitous and suggest a link between these diseases involving the BRAFV600E mutation. Key Points The association of both Langerhans cell histiocytosis and Erdheim-Chester disease is not exceptional. This association is linked to BRAFV600E mutation.This publication has 49 references indexed in Scilit:
- Pathogenesis of Langerhans Cell HistiocytosisAnnual review of pathology, 2013
- BRAFMutations in Hairy-Cell LeukemiaThe New England Journal of Medicine, 2011
- Pulmonary involvement in Erdheim‐Chester disease: A single‐center study of thirty‐four patients and a review of the literatureArthritis & Rheumatism, 2010
- Recurrent BRAF mutations in Langerhans cell histiocytosisBlood, 2010
- Development of Monocytes, Macrophages, and Dendritic CellsScience, 2010
- 18F‐fluorodeoxyglucose–positron emission tomography scanning is more useful in followup than in the initial assessment of patients with Erdheim‐Chester diseaseArthritis & Rheumatism, 2009
- Cardiac Involvement in Erdheim-Chester DiseaseCirculation, 2009
- Blood Monocytes: Development, Heterogeneity, and Relationship with Dendritic CellsAnnual Review of Immunology, 2009
- Parallel occurrence of Erdheim-Chester disease and eosinophilic granuloma in the same patientJournal of the European Academy of Dermatology and Venereology, 2009
- A rare cause of cardiac tumour: an Erdheim–Chester disease with cardiac involvement co-existing with an intracerebral Langerhans cell histiocytosisEuropean Heart Journal, 2008